Salon, Alicia L.

HRN: 28-85-61  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/14/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
04/14/2026
04/21/2026
IV
2.25g
Q 6
CAP-MR
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: